Next Article in Journal
Influence of Lipid A Acylation Pattern on Membrane Permeability and Innate Immune Stimulation
Previous Article in Journal
Towards the Small and the Beautiful: A Small Dibromotyrosine Derivative from Pseudoceratina sp. Sponge Exhibits Potent Apoptotic Effect through Targeting IKK/NFκB Signaling Pathway
Open AccessArticle

Sarcophyolides B–E, New Cembranoids from the Soft Coral Sarcophyton elegans

State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China
Chemical Analysis Department, Beijing Entry-Exit Inspection and Quarantine Bureau, Beijing 100026, China
Naturalis Biodiversity Center, National Museum of Natural History, Leiden 2300, The Netherlands
Institute of Pharmaceutical Biology and Biotechnology, Heinrich-Heine University, 40225 Duesseldorf, Germany
Author to whom correspondence should be addressed.
Mar. Drugs 2013, 11(9), 3186-3196;
Received: 28 May 2013 / Revised: 28 June 2013 / Accepted: 12 July 2013 / Published: 26 August 2013
PDF [695 KB, uploaded 24 February 2015]


Four new cembrane-type diterpenoids, sarcophyolides B–E (14), along with 11 known analogues were isolated from the soft coral Sarcophyton elegans. The structures of new compounds 14 were established on the basis of spectroscopic analysis and chemical conversion. The new cembranoids sarcophyolides B (1) and lobocrasol were found to exhibit potent inhibition against A2780 human ovarian tumor cells. View Full-Text
Keywords: soft coral; Sarcophyton elegans; sarcophyolide; cembranoid; cytotoxicity soft coral; Sarcophyton elegans; sarcophyolide; cembranoid; cytotoxicity

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Supplementary materials


Share & Cite This Article

MDPI and ACS Style

Xi, Z.; Bie, W.; Chen, W.; Liu, D.; Ofwegen, L.V.; Proksch, P.; Lin, W. Sarcophyolides B–E, New Cembranoids from the Soft Coral Sarcophyton elegans. Mar. Drugs 2013, 11, 3186-3196.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top